Logo image of EXL.DE

EXASOL AG (EXL.DE) Stock Fundamental Analysis

Europe - FRA:EXL - DE000A0LR9G9 - Common Stock

3 EUR
+0.01 (+0.33%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

5

Overall EXL gets a fundamental rating of 5 out of 10. We evaluated EXL against 110 industry peers in the Software industry. EXL is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. EXL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

EXL had positive earnings in the past year.
EXL had a positive operating cash flow in the past year.
EXL had negative earnings in 4 of the past 5 years.
EXL had negative operating cash flow in 4 of the past 5 years.
EXL.DE Yearly Net Income VS EBIT VS OCF VS FCFEXL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M

1.2 Ratios

The Return On Assets of EXL (7.17%) is better than 67.27% of its industry peers.
EXL has a Return On Equity of 30.87%. This is amongst the best in the industry. EXL outperforms 90.00% of its industry peers.
The Return On Invested Capital of EXL (3.67%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 7.17%
ROE 30.87%
ROIC 3.67%
ROA(3y)-34.86%
ROA(5y)-43.4%
ROE(3y)-152.02%
ROE(5y)-136.22%
ROIC(3y)N/A
ROIC(5y)N/A
EXL.DE Yearly ROA, ROE, ROICEXL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

EXL has a Profit Margin (4.48%) which is comparable to the rest of the industry.
EXL has a Operating Margin (3.19%) which is comparable to the rest of the industry.
With an excellent Gross Margin value of 88.94%, EXL belongs to the best of the industry, outperforming 87.27% of the companies in the same industry.
EXL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.19%
PM (TTM) 4.48%
GM 88.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.92%
GM growth 5Y-0.71%
EXL.DE Yearly Profit, Operating, Gross MarginsEXL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EXL is destroying value.
EXL has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for EXL has been increased compared to 5 years ago.
There is no outstanding debt for EXL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EXL.DE Yearly Shares OutstandingEXL.DE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
EXL.DE Yearly Total Debt VS Total AssetsEXL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 4.11 indicates that EXL is not in any danger for bankruptcy at the moment.
With a Altman-Z score value of 4.11, EXL perfoms like the industry average, outperforming 59.09% of the companies in the same industry.
There is no outstanding debt for EXL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.11
ROIC/WACC0.46
WACC7.97%
EXL.DE Yearly LT Debt VS Equity VS FCFEXL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

2.3 Liquidity

EXL has a Current Ratio of 44.59. This indicates that EXL is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 44.59, EXL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 44.18 indicates that EXL has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 44.18, EXL belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 44.59
Quick Ratio 44.18
EXL.DE Yearly Current Assets VS Current LiabilitesEXL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

EXL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 158.81%, which is quite impressive.
The Revenue has grown by 13.18% in the past year. This is quite good.
EXL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.89% yearly.
EPS 1Y (TTM)158.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%621.43%
Revenue 1Y (TTM)13.18%
Revenue growth 3Y13.01%
Revenue growth 5Y12.89%
Sales Q2Q%10.43%

3.2 Future

Based on estimates for the next years, EXL will show a very strong growth in Earnings Per Share. The EPS will grow by 200.00% on average per year.
EXL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.42% yearly.
EPS Next Y750%
EPS Next 2Y318.33%
EPS Next 3Y200%
EPS Next 5YN/A
Revenue Next Year7.2%
Revenue Next 2Y7.25%
Revenue Next 3Y8.3%
Revenue Next 5Y10.42%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
EXL.DE Yearly Revenue VS EstimatesEXL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M 100M
EXL.DE Yearly EPS VS EstimatesEXL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 42.86 indicates a quite expensive valuation of EXL.
EXL's Price/Earnings ratio is in line with the industry average.
EXL's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.42.
With a Price/Forward Earnings ratio of 16.97, EXL is valued correctly.
80.91% of the companies in the same industry are more expensive than EXL, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of EXL to the average of the S&P500 Index (22.94), we can say EXL is valued slightly cheaper.
Industry RankSector Rank
PE 42.86
Fwd PE 16.97
EXL.DE Price Earnings VS Forward Price EarningsEXL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EXL is valued a bit cheaper than the industry average as 67.27% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXL indicates a somewhat cheap valuation: EXL is cheaper than 60.91% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 39.13
EV/EBITDA 17.89
EXL.DE Per share dataEXL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXL's earnings are expected to grow with 200.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.06
PEG (5Y)N/A
EPS Next 2Y318.33%
EPS Next 3Y200%

0

5. Dividend

5.1 Amount

No dividends for EXL!.
Industry RankSector Rank
Dividend Yield N/A

EXASOL AG

FRA:EXL (10/17/2025, 7:00:00 PM)

3

+0.01 (+0.33%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-12 2025-08-12
Earnings (Next)11-12 2025-11-12
Inst Owners10.25%
Inst Owner ChangeN/A
Ins Owners3.72%
Ins Owner ChangeN/A
Market Cap80.64M
Analysts83.33
Price Target5.2 (73.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)21.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.93%
Valuation
Industry RankSector Rank
PE 42.86
Fwd PE 16.97
P/S 1.94
P/FCF 39.13
P/OCF 30.35
P/B 13.34
P/tB 15.95
EV/EBITDA 17.89
EPS(TTM)0.07
EY2.33%
EPS(NY)0.18
Fwd EY5.89%
FCF(TTM)0.08
FCFY2.56%
OCF(TTM)0.1
OCFY3.29%
SpS1.55
BVpS0.22
TBVpS0.19
PEG (NY)0.06
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.17%
ROE 30.87%
ROCE 5.21%
ROIC 3.67%
ROICexc 27.93%
ROICexgc 39.64%
OM 3.19%
PM (TTM) 4.48%
GM 88.94%
FCFM 4.95%
ROA(3y)-34.86%
ROA(5y)-43.4%
ROE(3y)-152.02%
ROE(5y)-136.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.92%
GM growth 5Y-0.71%
F-Score7
Asset Turnover1.6
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 30.72%
Cap/Sales 1.43%
Interest Coverage 265.94
Cash Conversion 81.26%
Profit Quality 110.42%
Current Ratio 44.59
Quick Ratio 44.18
Altman-Z 4.11
F-Score7
WACC7.97%
ROIC/WACC0.46
Cap/Depr(3y)7.45%
Cap/Depr(5y)49.4%
Cap/Sales(3y)0.53%
Cap/Sales(5y)5.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)158.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%621.43%
EPS Next Y750%
EPS Next 2Y318.33%
EPS Next 3Y200%
EPS Next 5YN/A
Revenue 1Y (TTM)13.18%
Revenue growth 3Y13.01%
Revenue growth 5Y12.89%
Sales Q2Q%10.43%
Revenue Next Year7.2%
Revenue Next 2Y7.25%
Revenue Next 3Y8.3%
Revenue Next 5Y10.42%
EBIT growth 1Y136.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3950.5%
EBIT Next 3Y343.11%
EBIT Next 5YN/A
FCF growth 1Y126.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y134.48%
OCF growth 3YN/A
OCF growth 5Y-9.08%